Audited Results of Piramal Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	4,782.01	5,285.71	4,390.11	3,443.22	3,094.95
Manufacturing Expenses	131.53	131.62	112.89	107.94	68.97
Personnel Expenses	744.82	736.19	613.93	548.50	425.30
Selling Expenses	148.09	138.26	107.33	138.71	122.94
Administrative Expenses	945.86	890.89	743.26	699.25	543.26
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	4,140.01	4,245.27	3,772.19	3,345.69	2,697.65
Operating Profit	642	1,040.44	617.92	97.53	397.30
Other Recurring Income	662.73	207.35	202.06	341.07	223.59
Adjusted PBDIT	1,304.73	1,247.79	819.98	438.60	620.89
Financial Expenses	79.95	114.56	107.10	115.87	53.55
Depreciation	255.50	222.09	205.26	192.08	130.64
Other Write offs	0	0	0	0	0
Adjusted PBT	969.28	911.14	507.62	130.65	436.70
Tax Charges	176.76	219.74	116.40	54.19	81.18
Adjusted PAT	792.52	691.40	391.22	76.46	355.52
Non Recurring Items	-101.86	-6.17	-3.78	-9.53	-12.18
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	700.01	691.40	391.22	69.50	343.05
Equity Dividend	18.54	14.47	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	2,709.33	2,029.99	1,359.23	985.19	912.38

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article